Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy

The blockade of programmed cell death protein 1 (PD-1) as monotherapy has been widely used in melanoma, but to identify melanoma patients with survival benefit from anti-PD-1 monotherapy is still a big challenge. There is an urgent need for prognostic signatures improving the prediction of immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian-Guo, Liang, Bo, Liu, Jian-Guo, Jin, Su-Han, He, Si-Si, Frey, Benjamin, Gu, Ning, Fietkau, Rainer, Hecht, Markus, Ma, Hu, Gaipl, Udo S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143567/
https://www.ncbi.nlm.nih.gov/pubmed/33922038
http://dx.doi.org/10.3390/cells10050977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143567/
https://www.ncbi.nlm.nih.gov/pubmed/33922038
http://dx.doi.org/10.3390/cells10050977

Ejemplares similares